↑Duan J, Dahlback B, Villoutreix BO (Jun 2001). "Proposed lipocalin fold for apolipoprotein M based on bioinformatics and site-directed mutagenesis". FEBS Lett. 499 (1–2): 127–32. doi:10.1016/S0014-5793(01)02544-3. PMID11418126.
Albertella MR, Jones H, Thomson W, et al. (1997). "Localization of eight additional genes in the human major histocompatibility complex, including the gene encoding the casein kinase II beta subunit (CSNK2B)". Genomics. 36 (2): 240–51. doi:10.1006/geno.1996.0459. PMID8812450.
Xu N, Zhang XY, Dong X, et al. (2002). "Effects of platelet-activating factor, tumor necrosis factor, and interleukin-1alpha on the expression of apolipoprotein M in HepG2 cells". Biochem. Biophys. Res. Commun. 292 (4): 944–50. doi:10.1006/bbrc.2002.6755. PMID11944906.
Zhang XY, Dong X, Zheng L, et al. (2003). "Specific tissue expression and cellular localization of human apolipoprotein M as determined by in situ hybridization". Acta Histochem. 105 (1): 67–72. doi:10.1078/0065-1281-00687. PMID12666989.
Mungall AJ, Palmer SA, Sims SK, et al. (2003). "The DNA sequence and analysis of human chromosome 6". Nature. 425 (6960): 805–11. doi:10.1038/nature02055. PMID14574404.
Richter S, Shih DQ, Pearson ER, et al. (2004). "Regulation of apolipoprotein M gene expression by MODY3 gene hepatocyte nuclear factor-1alpha: haploinsufficiency is associated with reduced serum apolipoprotein M levels". Diabetes. 52 (12): 2989–95. doi:10.2337/diabetes.52.12.2989. PMID14633861.
Zhang XY, Jiao GQ, Hurtig M, et al. (2005). "Expression pattern of apolipoprotein M during mouse and human embryogenesis". Acta Histochem. 106 (2): 123–8. doi:10.1016/j.acthis.2003.11.004. PMID15147633.
Kabbara A, Payet N, Cottel D, et al. (2004). "Exclusion of CYP46 and APOM as candidate genes for Alzheimer's disease in a French population". Neurosci. Lett. 363 (2): 139–43. doi:10.1016/j.neulet.2004.03.066. PMID15172102.
Xu N, Nilsson-Ehle P, Ahrén B (2005). "Correlation of apolipoprotein M with leptin and cholesterol in normal and obese subjects". J. Nutr. Biochem. 15 (10): 579–82. doi:10.1016/j.jnutbio.2004.03.001. PMID15542348.
Luo G, Hurtig M, Zhang X, et al. (2005). "Leptin inhibits apolipoprotein M transcription and secretion in human hepatoma cell line, HepG2 cells". Biochim. Biophys. Acta. 1734 (2): 198–202. doi:10.1016/j.bbalip.2005.02.005. PMID15904876.
Niu N, Zhu X, Liu Y, et al. (2007). "Single nucleotide polymorphisms in the proximal promoter region of apolipoprotein M gene (apoM) confer the susceptibility to development of type 2 diabetes in Han Chinese". Diabetes Metab. Res. Rev. 23 (1): 21–5. doi:10.1002/dmrr.641. PMID16572495.
Christoffersen C, Nielsen LB, Axler O, et al. (2006). "Isolation and characterization of human apolipoprotein M-containing lipoproteins". J. Lipid Res. 47 (8): 1833–43. doi:10.1194/jlr.M600055-JLR200. PMID16682745.
Karlsson H, Lindqvist H, Tagesson C, Lindahl M (2006). "Characterization of apolipoprotein M isoforms in low-density lipoprotein". J. Proteome Res. 5 (10): 2685–90. doi:10.1021/pr060180x. PMID17022639.
Xu X, Ye Q, Xu N, et al. (2007). "Effects of ischemia-reperfusion injury on apolipoprotein M expression in the liver". Transplant. Proc. 38 (9): 2769–73. doi:10.1016/j.transproceed.2006.08.133. PMID17112825.
Ahnström J, Faber K, Axler O, Dahlbäck B (2007). "Hydrophobic ligand binding properties of the human lipocalin apolipoprotein M". J. Lipid Res. 48 (8): 1754–62. doi:10.1194/jlr.M700103-JLR200. PMID17525477.